PERCUTANEOUS RADIO FREQUENCY ABLATION FOR HEMATURIA

Bradford J. Wood, James Grippo, Christian P. PavlovichThe Journal of Urology 2001 · DOI

TL;DR

This paper presents a case study of using percutaneous radiofrequency (RF) ablation to successfully treat severe hematuria in a patient with a solitary kidney and a large renal cell carcinoma. This minimally invasive technique offered a viable alternative when traditional embolization failed, highlighting its potential for managing challenging bleeding scenarios in patients with compromised renal function.

What Problem Does This Paper Address?

The paper addresses the challenge of managing persistent, life-threatening hematuria originating from a renal tumor, particularly in patients who are not good candidates for traditional surgical intervention. Specifically, it focuses on a patient with a solitary kidney and chronic renal insufficiency, making nephrectomy a high-risk option. While arterial embolization is a common approach for controlling such bleeding, it can be technically difficult and may not always be fully effective, especially with complex tumor vascularity. The authors explore RF ablation as a secondary treatment option when embolization proves insufficient, aiming to control bleeding without sacrificing the remaining kidney function.

Methods

The core method employed is percutaneous radiofrequency (RF) ablation. This involves:

  1. Image Guidance: The procedure was performed under ultrasound monitoring.
  2. Probe Placement: A 17.5-gauge RF probe was percutaneously inserted into the renal tumor.
  3. Ablation Delivery: A 3 cm active tip needle-probe and a 200-watt, 480 kHz ablation system were used.
  4. Treatment Protocol: Three sessions, each lasting 12 minutes, were delivered to overlapping spheres within the tumor to ensure comprehensive thermal destruction.

This approach is contrasted with selective arterial embolization, which was attempted prior to RF ablation. In this case, embolization used polyvinyl alcohol particles to occlude the two primary segmental feeders of the tumor.

Datasets

Not discussed in the paper. The paper describes a single case study.

Key Insights and Ideas

  • RF Ablation as a Salvage Therapy: The study demonstrates that RF ablation can be a successful secondary treatment for persistent hematuria when less invasive methods like selective embolization fail, especially in complex patient profiles.
  • Preservation of Renal Function: For patients with a solitary kidney or compromised renal function, RF ablation offers a way to control tumor-related bleeding without resorting to nephrectomy, thereby preserving vital kidney function.
  • Tumor Response Variability: While RF ablation effectively stopped gross hematuria, follow-up imaging (MRI) indicated that the tumor was only partially ablated, with residual enhancement suggesting viable tumor cells at the periphery. This highlights that while effective for bleeding control, long-term oncological efficacy might require further investigation or combination therapies.
  • Recurrence and Spontaneous Resolution: The patient experienced a recurrence of hematuria after 8 months, which resolved spontaneously without further intervention. This suggests a dynamic process of tumor response and potential self-limitation of bleeding episodes in some cases.

Key Results

  • Hematuria Resolution: Gross hematuria resolved within 24 hours following RF ablation.
  • Bladder Irrigation Discontinuation: Continuous bladder irrigation was discontinued two days after the procedure.
  • Partial Tumor Ablation: Follow-up MRI at 4 weeks showed areas of necrosis but also noted enhancement toward the renal pelvis, indicating partial ablation.
  • Tumor Growth: At 5-month follow-up, MRI showed interval growth of the enhancing portion of the tumor, though the overall tumor size remained unchanged.
  • Hematuria Recurrence and Resolution: Gross hematuria recurred after 8 months and resolved spontaneously.
  • Stable Renal Function: Creatinine levels remained stable throughout the 8-month follow-up period.

Limitations and Future Work

  • Limited Oncological Efficacy: The paper acknowledges that it is still unknown whether RF ablation can provide long-term cancer control. The observed residual enhancement and interval growth of the tumor support this concern.
  • Single Case Study: The findings are based on a single patient, limiting the generalizability of the results.
  • Future Directions: The authors suggest that ultrasound-guided percutaneous RF ablation may be a useful alternative management modality for upper tract hematuria in select patients and warrants further study, particularly as an adjunct to selective embolization. They also imply the need for further research into the long-term oncological outcomes of this technique.

Summary updated

Abstract

No AccessJournal of UrologyCLINICAL UROLOGY: Case Reports1 Dec 2001PERCUTANEOUS RADIO FREQUENCY ABLATION FOR HEMATURIA BRADFORD J. WOOD, JAMES GRIPPO, and CHRISTIAN P. PAVLOVICH BRADFORD J. WOODBRADFORD J. WOOD , JAMES GRIPPOJAMES GRIPPO , and CHRISTIAN P. PAVLOVICHCHRISTIAN P. PAVLOVICH View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)65560-7AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "PERCUTANEOUS RADIO FREQUENCY ABLATION FOR HEMATURIA." The Journal of Urology, 166(6), pp. 2303–2304 References 1 : The role of arterial embolization in renal cell carcinoma. Scand J Urol Nephrol1999; 33: 162. Google Scholar 2 : Radiofrequency ablation of renal cell carcinoma: early clinical experience. Radiology2000; 217: 665. Google Scholar 3 : Combined embolization and percutaneous radiofrequency ablation of a solid renal tumor. AJR Am J Roentgenol2000; 174: 1592. Google Scholar From the Special Procedures-Diagnostic Radiology Department, Clinical Center, National Cancer Institute, Urologic Oncology Branch, National Institutes of Health, Bethesda, Maryland© 2001 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 166Issue 6December 2001Page: 2303-2304 Advertisement Copyright & Permissions© 2001 by American Urological Association, Inc.Keywordsablationtherapeutic embolizationhematuriarenal cell carcinomaradiofrequency ablationMetricsAuthor Information BRADFORD J. WOOD More articles by this author JAMES GRIPPO More articles by this author CHRISTIAN P. PAVLOVICH More articles by this author Expand All Advertisement PDF downloadLoading ...
BibTeX
@article{wood2001percutaneous,
  author = {Bradford J. Wood and JAMES GRIPPO and Christian P. Pavlovich},
  title = {{PERCUTANEOUS RADIO FREQUENCY ABLATION FOR HEMATURIA}},
  journal = {The Journal of Urology},
  year = {2001},
  doi = {10.1016/s0022-5347(05)65560-7},
}
Figure